Scarica l'app Stockscreener
23.50
0.13%
0.03
Dopo l'orario di chiusura:
24.80
1.30
+5.53%
Beta Bionics Inc Borsa (BBNX) Ultime notizie
Eventide Asset Management, LLC Acquires Significant Stake in Bet - GuruFocus.com
Artificial Pancreas Maker Beta Bionics Just Started Trading. Should You Buy BBNX Stock After Its IPO? - Barchart
Beta Bionics: A Sugar Rush For This IPO (NASDAQ:BBNX) - Seeking Alpha
Signals Recap: Ozempic's Latest Approval, EKDA on Reddit, Lilly Stops Relaxin, Beta Bionics IPO, NKF Turns 75, & More... - substack.com
Obesity-drug maker Metsera posts largest gain as IPOs defy market swoon - MSN
Beta Bionics Announces Closing of $234.6 Million Initial - GlobeNewswire
BBNXBeta Bionics, Inc. Latest Stock News & Market Updates - StockTitan
Oil company Infinity Natural Resources debuts IPO amid deregulation push - MSN
4 Firms Guide Pair Of Biotech IPOs Raising $415M Combined - Law360
Beta Bionics raises $204M in IPO - MedTech Dive
Beta Bionics stock opens 29% higher in Nasdaq debut - MSN
Beta Bionics (BBNX) Opens At $22, IPO Priced At $17 By Investing.com - Investing.com Canada
Beta Bionics Goes Public After Raising $204M Upsized Offering - Orange County Business Journal
Bionics Upsized $204M IPO: A Game-Changer for Diabetes Treatment - USA Herald
Beta Bionics raises $204m to kickstart medtech IPO season - Medical Device Network
Beta Bionics Shares Rise in Nasdaq Debut -January 30, 2025 at 12:39 pm EST - Marketscreener.com
Cooley, Latham Steer Beta Bionics' Upsized $204M IPO - Law360
Beta Bionics Rings the Opening Bell - Nasdaq
Insulin delivery device maker Beta Bionics prices further upsized IPO at $17, the high end of the upwardly revised range - Renaissance Capital
Artificial pancreas maker Beta Bionics aims to raise $204M in Nasdaq IPO - MSN
Beta Bionics Set to Revolutionize Diabetes Management with $204 Million IPO! - Mi Valle
Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering - GlobeNewswire
Beta Bionics sets terms for upsized $165M IPO - MSN
Beta Bionics sets terms for upsized $165M IPO (BBNX:Pending) - Seeking Alpha
Beta Bionics targets $695 million valuation in upsized US IPO - MSN
BBNX IPO NewsInsulin delivery device maker Beta Bionics increases deal size by 47% ahead of $165 million IPO - Renaissance Capital
IPO Roundup: Smithfield Foods, Beta Bionics and more - MSN
Obesity-Focused Metsera Leads Biotech Firms Eyeing IPOs - Law360
Beta Bionics targets $114M IPO raise to fund insulin pump development - MedTech Dive
Beta Bionics, Inc. (BBNX) Announces January 30th IPO - Defense World
Beta Bionics joins IPO uptick, aims to raise $114.4m in Nasdaq listing - MSN
Beta Bionics Targets $113 Million in IPO, Plans Nasdaq Listing - GuruFocus.com
Beta Bionics sets terms for upsized $113M IPO - MSN
S&P 500 Growth (IGX) QuotePress Release - The Globe and Mail
Beta Bionics Announces Plans for IPO - Orange County Business Journal
Beta Bionics Aims For IPO To Cover Heavy Losses (BBNX) - Seeking Alpha
Beta Bionics, maker of ‘bionic pancreas,’ files for IPO - MedTech Dive
Oilfield Services Firm Flowco Set to Drill Down On $392M IPO - Law360
Beta Bionics Files Registration Statement for Proposed Initial Public Offering - GlobeNewswire
Beta Bionics Raises $60M Series E - Orange County Business Journal
Beta Bionics Announces Closing of a $60 Million Series E Financing - Newswire
Diabetes Dialogue: Diabetes Tech Updates in October 2024 - MD Magazine
Beta Bionics Announces Launch of the iLet Bionic Pancreas With Abbott’s FreeStyle Libre 3 Plus Sensor - Newswire
Abbott expands pump partnerships, launches Lingo CGM - BioWorld Online
Beta Bionics Announces Partnership With Abbott to Integrate the iLet Bionic Pancreas With the FreeStyle Libre 3 Plus iCGM - Yahoo Finance
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics - Business Wire
Beta Bionics’ iLet bionic pancreas launches worldwide - Medical Device Network
First AID positions Dexcom for healthy new year - BioWorld Online
Beta Bionics Announces iLet Bionic Pancreas Is Now Added to the Express Scripts National Commercial Formularies - Newswire
Beta Bionics Secures $100M in Series D - MPO-mag
Beta Bionics closes $100M Series D to support bionic pancreas - Drug Delivery Business News
Beta Bionics Secures $100 Million in Series D Funding to Advance Diabetes Technology and Expand Market Presence - The Globe and Mail
Artificial Pancreas Devices System Market Expected to Witness a Sustainable Growth Over 2031 | Medtronic, Inc., JDRF, Johnson & Johnson, Beta Bionics, Inc. - Industry Today
Beta Bionics gains FDA clearance for prefilled insulin cartridge - Medical Device Network
Beta Bionics Announces FDA Clearance for the Use of a Prefilled Insulin Cartridge With the iLet Bionic Pancreas - Newswire
Beta Bionics’ automated insulin delivery system picks up manufacturing partner - Pharmaceutical Technology
Beta Bionics Announces FDA Clearance and Commercialization of the iLet Bionic Pancreas - Newswire
Beta Bionics Appoints Dr. Steven Russell as Chief Medical Officer in Preparation for the Commercial Launch of the iLet Bionic Pancreas System - Newswire
“Bionic pancreas” improves blood sugar control in Type 1 diabetics: Newsroom - UT Southwestern
Bionic pancreas improves type 1 diabetes management compared to standard insulin delivery methods - National Institutes of Health
Beta Bionics Appoints Sean Saint as CEO - citybiz
The iLet® Bionic Pancreas Significantly Reduced HbA1c and - GlobeNewswire
Beta Bionics Announces Executive Leadership and Board - GlobeNewswire
Beta Bionics Announces Closing of $57 Million Series C Financing - GlobeNewswire
Beta Bionics Announces Data Lock of the Insulin-Only Bionic - GlobeNewswire
Beta Bionics Announces the Appointment of Martha Goldberg Aronson as Chair of Its Board of Directors - Business Wire
1.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):